CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 202 enrolled
Drug / intervention
Home blood pressure monitoringdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04823949
NCT04823949N/ACompleted

Remote Monitoring Compared With In-Office Surveillance of Blood Pressures in Patients With Pregnancy-Related Hypertension: A Randomized Controlled Trial

Prisma Health-Upstate·interventional·Posted Apr 1, 2021·Updated May 18, 2023

In Brief

A clinical study evaluating Home blood pressure monitoring for Gestational Hypertension and 3 related conditions. Completed, enrolled 202 participants across 2 sites.

Detailed Summary

A large segment of our patient population is diagnosed with hypertensive disorders of pregnancy, including gestational hypertension and pre-eclampsia. New guidelines from the American College of Obstetricians and Gynecologists recommend postpartum monitoring of blood pressures via blood pressure checks on day 3 postpartum and between days 7-10 postpartum. Our purpose is to compare the effectiveness of using a Bluetooth-enabled home blood pressure monitoring platform to the standard postpartum office-based blood pressure monitoring in performing the recommended postpartum follow-up for patients with hypertensive disorders of pregnancy.

Study Details

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 1, 2021
Enrollment StartApr 15, 2021
Primary CompletionJan 18, 2022
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 5.3 years ago

Interventions

Home blood pressure monitoringdevice

See arm description